J Korean Med Assoc Search


J Korean Med Assoc > Volume 59(10); 2016 > Article
Journal of the Korean Medical Association 2016;59(10):775-784.
Published online October 19, 2016.
DOI: https://doi.org/10.5124/jkma.2016.59.10.775   
Recent advances in ischemic stroke management
Cindy W Yoon, Joung Ho Rha
Department of Neurology, Inha University School of Medicine, Incheon, Korea. jhrha@inha.ac.kr
There have been recent advances in the hyperacute treatment and secondary prevention of ischemic stroke. Thrombolysis with intravenous tissue plasminogen activator has been approved for a 3 to 4.5 hour time window, but the recent controversy over the optimal dose has not been resolved. Five endovascular trials published in 2015 have shown dramatically positive results. Regarding secondary prevention of ischemic stroke, a study suggesting the beneficial effect of a short course of dual antiplatelet therapy has been published. Non-vitamin K antagonist oral anticoagulation agents have been approved for stroke prevention in non-valvular atrial fibrillation. Here, we review these recent advances in ischemic stroke management.
Key Words: Stroke, Tissue plasminogen activator, Endovascular procedures, Platelet aggregation inhibitors, Anticoagulants


Browse all articles >

Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@kma.org                

Copyright © 2022 by Korean Medical Association.

Developed in M2PI

Close layer
prev next